![Albion Fitzgerald](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Albion Fitzgerald
Geen lopende functies
Profiel
Albion J.
Fitzgerald was the founder of Novadigm, Inc. founded in 1992, where he held the titles of Chairman, Chief Executive & Technology Officer from 1995 to 2004.
Mr. Fitzgerald is also the founder of Telemetrix, Inc. Mr. Fitzgerald's former jobs include Chairman & Chief Executive Officer at ManageIQ, Inc. from 2007 to 2012, and Independent Director at CohBar, Inc. from 2014 to 2023.
Eerdere bekende functies van Albion Fitzgerald
| Bedrijven | Functie | Einde |
|---|---|---|
| COHBAR | Voorzitter | 01-04-2021 |
ManageIQ, Inc.
 ManageIQ, Inc. Packaged SoftwareTechnology Services Provides enterprise cloud management and automation solutions | Algemeen Directeur | 01-12-2012 |
Novadigm, Inc.
 Novadigm, Inc. Packaged SoftwareTechnology Services Develops management software products | Algemeen Directeur | 01-01-2004 |
Telemetrix, Inc.
 Telemetrix, Inc. Wireless TelecommunicationsCommunications Provides wireless communications services | Algemeen Directeur | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
24
Eerstegraads connecties
4
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 4 |
|---|---|
Novadigm, Inc.
Novadigm, Inc. Packaged SoftwareTechnology Services Develops management software products | Technology Services |
Telemetrix, Inc.
Telemetrix, Inc. Wireless TelecommunicationsCommunications Provides wireless communications services | Communications |
ManageIQ, Inc.
ManageIQ, Inc. Packaged SoftwareTechnology Services Provides enterprise cloud management and automation solutions | Technology Services |
CohBar, Inc.
 CohBar, Inc. BiotechnologyHealth Technology Develops biotechnology products that intends to treat age-related diseases through the discovery of novel mitochondrial-derived peptides | Health Technology |
